MetLife Investment Management, LLC - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 213 filers reported holding LOXO ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2018$1,696,668
-18.0%
12,1130.0%0.02%
-4.5%
Q3 2018$2,069,264
-1.5%
12,1130.0%0.02%
-12.0%
Q2 2018$2,101,000
+70.7%
12,113
+13.6%
0.02%
+78.6%
Q1 2018$1,231,000
+37.1%
10,6660.0%0.01%
+40.0%
Q4 2017$898,00010,6660.01%
Other shareholders
LOXO ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aisling Capital LLC 3,438,920$289,488,00057.19%
DAFNA Capital Management LLC 296,000$24,917,00013.42%
Casdin Capital, LLC 360,000$30,305,0007.38%
Opaleye Management Inc. 176,300$14,841,0004.75%
DRIEHAUS CAPITAL MANAGEMENT LLC 574,495$48,361,0001.84%
SECTORAL ASSET MANAGEMENT INC 152,185$12,811,0001.60%
AWM Investment Company, Inc. 85,000$7,155,0001.39%
Eventide Asset Management 285,000$23,991,0001.25%
Rock Springs Capital Management LP 310,000$26,096,0001.18%
Crawford Lake Capital Management, LLC 53,420$4,497,0001.06%
View complete list of LOXO ONCOLOGY INC shareholders